Integration of NF-κB+ patient expression data showed that 35% of genes downregulated in the NFKB2 KD KMS-11 transcriptional profile were overexpressed in NF-κB+ primary MM tumours (Fig. 1f). This evidence concerns the gene NFKB2 and Miyoshi myopathy.